NCOA4: An Immunomodulation-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer.
J Oncol
; 2022: 5242437, 2022.
Article
in En
| MEDLINE
| ID: mdl-35756082
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
J Oncol
Year:
2022
Document type:
Article
Affiliation country:
China